Open AccessDesign of Mesoporous Silica Nanoparticles for the Treatment of Amyotrophic Lateral Sclerosis (ALS) with a Therapeutic Cocktail Based on Leptin and Pioglitazone
Author(s) -
Diana DíazGarcía,
Águeda Ferrer-Donato,
José M. MéndezArriaga,
Marta Cabrera-Pinto,
Miguel Díaz-Sánchez,
Sanjiv Prashar,
Carmen M. FernandezMartos,
Santiago GómezRuiz
Publication year - 2022
Publication title -
acs biomaterials science and engineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.082
H-Index - 50
ISSN - 2373-9878
DOI - 10.1021/acsbiomaterials.2c00865
Subject(s) - amyotrophic lateral sclerosis , pioglitazone , mesoporous silica , in vivo , nanocarriers , nanomedicine , neuroprotection , pharmacology , leptin , medicine , drug , disease , chemistry , type 2 diabetes , materials science , nanotechnology , diabetes mellitus , biology , nanoparticle , mesoporous material , endocrinology , obesity , biochemistry , microbiology and biotechnology , catalysis